Caffeoylquinic acid-rich extract from chicory seeds improves glycemia, atherogenic index, and antioxidant status in rats

Nutrition

Volumn 28, Issue 3, 2012, Pages 300-306

  Jurgoński, Adam ^a   Juśkiewicz, Jerzy ^a   Zduńczyk, Zenon ^a   Król, Bogusław ^b  

^a INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

^b LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Caffeoylquinic acids; Chicory; Chlorogenic acid; Rutin; The metabolic syndrome

Indexed keywords

ALCOHOL; ALPHA GLUCOSIDASE; ANTIOXIDANT; BETA GALACTOSIDASE; BETA GLUCOSIDASE; CHLOROGENIC ACID; CHOLESTEROL; CICHORIUM INTYBUS EXTRACT; FRUCTOSE; GLUCOSE; GLUTATHIONE PEROXIDASE; PLANT EXTRACT; RUTOSIDE; SHORT CHAIN FATTY ACID; SOYBEAN OIL; SUCRASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CECUM; CHICORY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FERMENTATION; GLUCOSE BLOOD LEVEL; HEART; HYPERGLYCEMIA; KIDNEY; MALE; METABOLIC SYNDROME X; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CHICORY; DIETARY SUPPLEMENTS; FRUCTOSE; MALE; PHENOLS; PLANT EXTRACTS; QUINIC ACID; RATS; RATS, WISTAR; RUTIN; SEEDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

CICHORIUM INTYBUS; GLYCINE MAX; RATTUS; RATTUS NORVEGICUS; ZEA MAYS;

EID: 84856486063     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.06.010     Document Type: Article

References (42)

1. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome. Circulation 2009, 120:1640-1645.
2. Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004, 24:816-823.
3. Tappy L., Lê K.A., Tran C., Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition 2010, 26:1044-1049.
4. de Moura R.F., Ribeiro C., de Oliveira J.A., Stevanato E., de Mello M.A.R. Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols. Br J Nutr 2009, 101:1178-1184.
5. Busserolles J., Gueux E., Rock E., Demigne C., Mazur A., Rayssiguier Y. Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr 2003, 133:1903-1908.
6. Bischoff S.C. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr 2008, 11:733-740.
7. Fernandes A.A., Novelli E.L., Okoshi K., Okoshi M.P., Di Muzio B.P., Guimarães J.F., et al. Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomed Pharmacother 2010, 64:214-219.
8. Kamalakkannan N., Stanely Mainzen Prince P. Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol Cell Biochem 2006, 293:211-219.
9. Ziaee A., Zamansoltani F., Nassiri-Asl M., Abbasi E. Effects of rutin on lipid profile in hypercholesterolaemic rats. Basic Clin Pharmacol Toxicol 2009, 104:253-258.
10. Hsu C.L., Wu C.H., Huang S.L., Yen G.C. Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats. J Agric Food Chem 2009, 57:425-431.
11. Juśkiewicz J., Milala J., Jurgoński A., Król B., Zduńczyk Z. Consumption of polyphenol concentrate with dietary fructo-oligosaccharides enhances cecal metabolism of quercetin glycosides in rats. Nutrition 2011, 27:351-357.
12. Selma M.V., Espin J.C., Tomas-Barberan F.A. Interaction between phenolics and gut microbiota: role in human heath. J Agric Food Chem 2009, 57:6485-6501.
13. Azuma K., Ippoushi K., Nakayama M., Ito H., Higashio H., Terao J. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J Agric Food Chem 2000, 48:5496-5500.
14. Cho A.S., Jeon S.M., Kim M.J., Yeo J., Seo K.I., Choi M.S., et al. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol 2010, 48:937-943.
15. Johnston K.L., Clifford M.N., Morgan L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003, 78:728-733.
16. Wittemer S.M., Ploch M., Windeck T., Müller S.C., Drewelow B., Derendorf H., et al. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine 2005, 12:28-38.
17. Jurgoński A., Milala J., Juśkiewicz J., Zduńczyk Z., Król B. Composition of chicory root, peel, seed, and leaf ethanol extracts and biological properties of their non-fructan fractions. Food Technol Biotechnol 2011, 49:40-47.
18. Brand-Williams W., Cuvelier M.E., Berset C. Use of a free radical method to evaluate antioxidant activity. Lebensm Wiss Technol 1995, 28:25-30.
19. Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem 1964, 7:18-25.
20. Hofirek B., Haas D. Comparative studies of ruminal fluid collected by oral tube or by puncture of the caudorental ruminal sac. Acta Vet (Brno) 2001, 70:27-33.
21. Zduńczyk Z., Król B., Juśkiewicz J., Wróblewska M. Biological properties of fructooligosaccharides with different contents of kestose and nystose in rats. Arch Anim Nutr 2005, 59:247-256.
22. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzimol 1990, 86:421-431.
23. Papetti A., Daglia M., Aceti C., Sordelli B., Spini V., Carazzone C., et al. Hydroxycinnamic acid derivatives occurring in Cichorium endivia vegetables. J Pharm Biomed Anal 2008, 48:472-476.
24. Yang B., Meng Z., Dong J., Yan L., Zou L., Tang Z., et al. Metabolic profile of 1,5-dicaffeoylquinic acid in rats, an invivo and invitro study. Drug Metab Dispos 2005, 33:930-936.
25. Schutz K., Kammerer D., Carle R., Schieber A. Identification and quantification of caffeoylquinic acids and flavonolds from artichoke (Cynara scolymus L.) heads, juice, and pomace by HPLC-DAD-ESI/MSn. J Agric Food Chem 2004, 52:4090-4096.
26. Mabeau S., Baty-Julien C., Helias A.-B., Chodosas O., Surbled M., Metra P., et al. Antioxidant activity of artichoke extracts and by-products. Acta Horticul 2006, 730:491-496.
27. Van den Ende W., Ravi Valluru R. Sucrose, sucrosyl oligosaccharides, and oxidative stress: scavenging and salvaging?. J Exp Bot 2009, 60:9-18.
28. Cirillo P., Gersch M.S., Mu W., Scherer P.M., Kim K.M., Gesualdo L., et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 2009, 20:545-553.
29. Skoog S.M., Bharucha A.E. Dietary fructose and gastrointestinal symptoms: a review. Am J Gastroenterol 2004, 99:2046-2050.
30. Kishi K., Takase S., Goda T. Enhancement of sucrase-isomaltase gene expression induced by luminally administered fructose in rat jejunum. JNutr Biochem 1999, 10:8-12.
31. Matsui T., Ebuchi S., Fujise T., Abesundara K.J.M., Doi S., Yamada H., et al. Strong antihyperglycemic effects of water-soluble fraction of brazilian propolis and its bioactive constituent, 3,4,5-tri-o-caffeoylquinic acid. Biol Pharm Bull 2004, 27:1797-1803.
32. Atta-ur-Rahman, Zareen S., Choudhary M.I., Akhtar M.N., Khan S.N. alpha-Glucosidase inhibitory activity of triterpenoids from Cichorium intybus. JNat Prod 2008, 71:910-913.
33. Beylot M. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 2005, 93:163-168.
34. Zhu X.F., Zhang H.X., Lo R. Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J Agric Food Chem 2004, 52:7272-7278.
35. Wilson R., Lyall K., Smyth L., Fernie C.E., Riemersma R.A. Dietary hydroxy fatty acids are absorbed in humans: implications for the measurement of 'oxidative stress' invivo. Free Radic Biol Med 2002, 32:162-168.
36. Onat A., Can G., Kaya H., Hergen G. Atherogenic index of plasma (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 2010, 4:89-98.
37. Scheffler W., Schwartzkopff W. Frequently used lipid-lowering drugs having no guaranteed effect. Artery 1980, 8:120-127.
38. Choi J., Park J.K., Lee K.T., Park K.K., Kim W.B., Lee J.H., et al. invivo antihepatotoxic effects of Ligularia fischeri var. spiciformis and the identification of the active component, 3,4-dicaffeoylquinic acid. J Med Food 2005, 8:348-352.
39. Cui C.-B., Jeong S.K., Lee Y.S., Lee S.O., Kang I.-J., Lim S.S. Inhibitory activity of caffeoylquinic acids from the aerial parts of Artemisia princeps on rat lens aldose reductase and on the formation of advanced glycation end products. J. Korean Soc Appl Biol Chem 2009, 52:655-662.
40. Yim M.B., Yim H.S., Lee C., Kang S.O., Chock P.B. Protein glycation: creation of catalytic sites for free radical generation. Ann NY Acad Sci 2001, 928:48-53.
41. Misciagna G., De Michele G., Trevisan M. Non enzymatic glycated proteins in the blood and cardiovascular disease. Curr Pharm Des 2007, 13:3688-3695.
42. Mishima S., Yoshida C., Akino S., Sakamoto T. Antihypertensive effects of Brazilian propolis: identification of caffeoylquinic acids as constituents involved in the hypotension in spontaneously hypertensive rats. Biol Pharm Bull 2005, 28:1909-1914.